|
Post by itellthefuture777 on Oct 2, 2017 9:01:11 GMT -5
If you are large pharma..you see Novo Nordisk has FAISP..and you..have no answer...most of your insulin factories are shut down in Peurto Rico..for several months..However Mannkind has a factory in Connecticut...capacity to handle global sales...now...Afrezza's new label blows FAISP... out of the water...Only question is..are you planning on staying relevant?
|
|
|
Post by itellthefuture777 on Oct 2, 2017 9:12:03 GMT -5
Now for Medtronic to make some announcement..hmmm
|
|
|
Post by careful2invest on Oct 2, 2017 9:14:54 GMT -5
Now for Medtronic to make some announcement..hmmm Wouldn't that be nice... But I am not going to hold my breath.
|
|
|
Post by itellthefuture777 on Oct 2, 2017 9:16:35 GMT -5
Dr Kaughman..article video said..in the next couple few days..So..Monday or Tuesday?
|
|
|
Post by itellthefuture777 on Oct 2, 2017 9:19:05 GMT -5
Maybe they will snap up those shares? hmmmm
|
|
|
Post by itellthefuture777 on Oct 2, 2017 12:05:01 GMT -5
Receptor Life Sciences was also mentioned..hmm..
|
|
|
Post by sellhighdrinklow on Oct 2, 2017 12:50:09 GMT -5
Most likely Big Pharma who is and has been shorting MNKD. If they are able to buy the company for 25% of true value, "they" win big. October trial results from Denver should help to move MNKD up BIG. JMHO
|
|
|
Post by wgreystone on Oct 2, 2017 13:12:22 GMT -5
There was a rumor last Friday that Merck already gave an offer to MNKD board. I would think it's better to fund MNKD instead of acquiring it. To acquire a company you have to pay good premium, while to fund a company you usually get good discount in SP.
|
|
|
Post by itellthefuture777 on Oct 2, 2017 13:21:59 GMT -5
There was a rumor last Friday that Merck already gave an offer to MNKD board. I would think it's better to fund MNKD instead of acquiring it. To acquire a company you have to pay good premium, while to fund a company you usually get good discount in SP. Last time I heard a rumor about Merck it was for I think $14..x 5 or $70 a share
|
|
|
Post by itellthefuture777 on Oct 2, 2017 13:24:32 GMT -5
There was a rumor last Friday that Merck already gave an offer to MNKD board. I would think it's better to fund MNKD instead of acquiring it. To acquire a company you have to pay good premium, while to fund a company you usually get good discount in SP. Last time I heard a rumor about Merck it was for I think $14..x 5 or $70 a share ...back then Al said he wouldn't sell for $125 a share...he said analyst were off by orders of magnitude...he said..Afrezza was purhaps the largest pharma opportunity in the history of pharma....Al's IQ was 176..and straight as an arrow. If Al said this is it...this is..it! I remember analyst saying this was a steal under $10 x 5 $50..It's definitely undervalued...but now that chain is off..hmmm up!
|
|
|
Post by kc on Oct 2, 2017 14:00:52 GMT -5
There was a rumor last Friday that Merck already gave an offer to MNKD board. I would think it's better to fund MNKD instead of acquiring it. To acquire a company you have to pay good premium, while to fund a company you usually get good discount in SP. You could do a layered buy into a company much like Medtronic is doing with Mazor Robotics. or the they Devil Sanofi did with Regeneron. I am sure that is what Al Mann wanted in the first place. Was a buy-in and not a buy-out.
|
|
|
Post by nadathing on Oct 2, 2017 14:12:39 GMT -5
Now for Medtronic to make some announcement..hmmm Please don't turn this into another YMB.
|
|
|
Post by od on Oct 2, 2017 16:32:57 GMT -5
Now for Medtronic to make some announcement..hmmm Please don't turn this into another YMB. Agree! Let's play this hand with the cards dealt.
|
|
|
Post by itellthefuture777 on Oct 2, 2017 16:39:17 GMT -5
Now for Medtronic to make some announcement..hmmm Please don't turn this into another YMB. I guess you havent read Dr Kaughman's transcripts?
|
|
|
Post by dreamboatcruise on Oct 2, 2017 16:39:52 GMT -5
Last time I heard a rumor about Merck it was for I think $14..x 5 or $70 a share ...back then Al said he wouldn't sell for $125 a share...he said analyst were off by orders of magnitude...he said..Afrezza was purhaps the largest pharma opportunity in the history of pharma....Al's IQ was 176..and straight as an arrow. If Al said this is it...this is..it! I remember analyst saying this was a steal under $10 x 5 $50..It's definitely undervalued...but now that chain is off..hmmm up! There has been a heck of a lot of dilution since then as well as shrinking of the pipeline. Back then there was promising oncology division. So unfortunately, what Al said way back then about share price can't be applied to the current situation.
|
|